Variables Modalities Breast side Right, Left Age Real Delay diagnosis—1st treatment Time Personal cancer history No, Yes Menopausal status No, Yes Cutaneous inflammation No, Yes Skin invasion No, Yes Clinical number of nodules 0, 1, ≥2 Clinical T stage (size) T0, T1, T2, T3, T4 Clinical N stage N0, N+ Number of tumours (histology) 0 or 1,
2 Tumour size (mm) (histology) Real Histological type Lobular, Ductal, Mixed, Microinvasive, Others SBR grade 1, 2, 3 Lymphatic embolus No, Yes Nervous colonisation No, Yes Necrosis (histology) No in situ component, In situ component without necrosisIn situ component with necrosisInfiltrating tumour associated with CIS Others,
75% in situ Limits of exeresis—infiltrating carcinoma Not in sano, In sano Skin—infiltrating tumour No or Not Applicable, Yes Skin—embolus No or Not Applicable, Yes Nipple—infiltrating tumour No or Not Applicable, Yes Nipple—cancer in situ No or Not Applicable, Yes Nipple—embolus No or Not Applicable, Yes Nipple—Paget’s disease No or Not Applicable, Yes Pectoral muscle invaded No or Not Applicable, Yes Number of invaded nodes 0, 1 or 2,
3 Nodes invaded N0, Micro metastasis, Macrometastasis Capsular breaking No, Yes Oestrogen receptor: % marked cells (count)
10%, (10–50)%,
50%Oestrogen receptor (intensity) +, ++/+++ Progesterone receptor: % marked cells (count) <10%,
%, >50% Progesterone receptor (intensity) +, ++/+++